Study guide
~/attachments/656a9f1b-e507-4e8c-93a8-fadefeec9679
file "/home/daytona/workspace/attachments/656a9f1b-e507-4e8c-93a8-fadefeec9679/Dβ¦
python -m markitdown "/home/daytona/workspace/attachments/656a9f1b-e507-4e8c-93aβ¦
cp "/home/daytona/workspace/attachments/656a9f1b-e507-4e8c-93a8-fadefeec9679/Docβ¦
cd /home/daytona/workspace/attachments/656a9f1b-e507-4e8c-93a8-fadefeec9679 && mβ¦
mkdir -p /home/daytona/workspace/pptx_extracted && cp "/home/daytona/workspace/aβ¦
unzip -o /home/daytona/workspace/pptx_extracted/pres.pptx -d /home/daytona/worksβ¦
ls /home/daytona/workspace/pptx_extracted/raw/ppt/slides/ | head -30
python3 << 'EOF' import os, re, glob slides_dir = "/home/daytona/workspace/pptxβ¦
python3 << 'EOF' import os, re, glob slides_dir = "/home/daytona/workspace/pptxβ¦
python3 << 'EOF' import os, re, glob slides_dir = "/home/daytona/workspace/pptxβ¦
| Category | Carbon skeleton yields | Examples |
|---|---|---|
| Glucogenic | Glucose precursors (pyruvate, Ξ±-KG, OAA, fumarate, succinyl-CoA) | Alanine, Aspartate, Glutamate, etc. |
| Ketogenic | Ketone bodies (acetyl-CoA, acetoacetate) | Leucine, Lysine |
| Both | Both glucose and ketone bodies | Isoleucine, Tryptophan, Phenylalanine, Tyrosine |
High-yield: Leucine & Lysine are the ONLY exclusively ketogenic AAs (cannot form glucose)
| AA | Pathway | Clinical note |
|---|---|---|
| Asparagine | β Aspartate β Oxaloacetate | Asparaginase depletes plasma asparagine - used in leukemia treatment |
| Aspartate | Transaminated β Oxaloacetate |
| AA | Pathway | Clinical note |
|---|---|---|
| Glutamine | β Glutamate β Ξ±-KG (via glutaminase & GDH) | |
| Proline, Arginine, Histidine | β all convert to Glutamate β Ξ±-KG | |
| Histidine | β FIGlu β Glutamate (folate-dependent) | FIGlu test detects folate deficiency |
| AA | Key steps |
|---|---|
| Alanine | Transaminated β Pyruvate; major gluconeogenic AA |
| Serine | β Glycine + Nβ΅,NΒΉβ°-methylene-THF; or β Pyruvate via serine dehydratase |
| Glycine | β Serine; also β COβ + NHβ; β Glyoxylate β Oxalate |
| Cystine | β Cysteine β Desulfuration β Pyruvate; sulfate β PAPS (activated sulfur donor) |
| Threonine | β Pyruvate OR β Ξ±-Ketobutyrate β Succinyl-CoA |
β οΈ Glycine β Oxalate pathway: excess oxalate causes kidney stones in Primary Oxaluria Type 1
| Step | Detail |
|---|---|
| Methionine β SAM | Major methyl donor in the body |
| SAM β SAH β Homocysteine | |
| Homocysteine β Methionine (remethylation) | Requires folate + Bββ |
| Homocysteine β Transsulfuration β Cysteine + Ξ±-Ketobutyrate β Propionyl-CoA β Succinyl-CoA | Requires Vitamin B6 |
| AA | Pathway |
|---|---|
| Valine & Isoleucine | β Propionyl-CoA β Succinyl-CoA (requires biotin & Bββ) |
| Threonine | β Ξ±-Ketobutyrate β Propionyl-CoA β Succinyl-CoA |
| AA | Products | Category |
|---|---|---|
| Leucine | Acetyl-CoA + Acetoacetate | Exclusively ketogenic |
| Isoleucine | Acetyl-CoA + Propionyl-CoA | Both glucogenic & ketogenic |
| Lysine | Acetoacetyl-CoA | Exclusively ketogenic (no transamination) |
| Tryptophan | Alanine + Acetoacetyl-CoA | Both glucogenic & ketogenic |
| Phenylalanine/Tyrosine | also yield acetoacetate | Both |
| Step | Enzyme | Cofactors |
|---|---|---|
| Transamination | Branched-chain aminotransferase | Vitamin Bβ |
| Oxidative Decarboxylation | Branched-chain Ξ±-keto acid dehydrogenase | TPP, lipoic acid, FAD, NADβΊ, CoA |
| Dehydrogenation | Forms Ξ±,Ξ²-unsaturated acyl-CoA |
β οΈ MSUD (Maple Syrup Urine Disease): deficiency in branched-chain Ξ±-keto acid dehydrogenase Isovaleryl-CoA dehydrogenase deficiency β "sweaty feet" odor
| AA synthesized | From |
|---|---|
| Alanine | β Pyruvate |
| Aspartate | β Oxaloacetate |
| Glutamate | β Ξ±-Ketoglutarate (also via glutamate dehydrogenase) |
| AA synthesized | Reaction |
|---|---|
| Glutamine | β Glutamate + NHβ (glutamine synthetase); ammonia transport form |
| Asparagine | β Aspartate + NHβ (asparagine synthetase); uses glutamine as NHβ donor |
| AA | Source |
|---|---|
| Proline | From glutamate β cyclization & reduction |
| Serine | From 3-phosphoglycerate OR from glycine via serine hydroxymethyltransferase + Nβ΅,NΒΉβ°-methylene-THF |
| Glycine | From serine (reverse of serine synthesis) |
| Cysteine | From methionine (via homocysteine) + serine; requires adequate dietary methionine |
| Tyrosine | From phenylalanine via phenylalanine hydroxylase; needs BHβ (regenerated by dihydropteridine reductase) |
| Feature | Detail |
|---|---|
| Defect | β Phenylalanine hydroxylase (or BHβ/dihydropteridine reductase deficiency) |
| Prevalence | 1 in 15,000 births |
| Biochemistry | β Phenylalanine, β Tyrosine β toxic: phenylpyruvate, phenyllactate, phenylacetate |
| CNS effects | Intellectual disability, seizures, microcephaly, failure to thrive |
| Urine odor | Musty/mousey (phenylketones) |
| Other signs | Hypopigmentation (light skin, hair, eyes - β melanin) |
| Screening | Universal newborn heel prick after 24-48 h of protein feeding |
| Treatment | Low-phenylalanine diet (start within 7-10 days), supplement tyrosine, avoid aspartame |
| Maternal PKU | High maternal Phe = teratogenic β fetal microcephaly, heart defects |
| Feature | Detail |
|---|---|
| Defect | β Branched-chain Ξ±-keto acid dehydrogenase |
| AAs affected | Leucine, Isoleucine, Valine |
| Symptoms | Poor feeding, vomiting, acidosis, maple syrup-smelling urine |
| Classic form | Severe, neonatal onset, lethal if untreated |
| Treatment | Lifelong restricted BCAA diet; thiamine in responsive cases |
| Feature | Detail |
|---|---|
| Defect | β Tyrosinase (blocks tyrosine β melanin) |
| Features | Hypopigmentation (skin, hair, eyes), photophobia, β visual acuity |
| Risk | β Skin cancer |
| Types | Autosomal recessive (most common); dominant/X-linked forms exist |
| Most severe | Tyrosinase-negative oculocutaneous albinism |
| Feature | Detail |
|---|---|
| Defect | β Cystathionine Ξ²-synthase (CBS) |
| Biochemistry | β Homocysteine & methionine, β Cysteine |
| Clinical | Ectopia lentis, skeletal abnormalities, thrombi, osteoporosis |
| B6-responsive form | Milder symptoms |
| Treatment | β Methionine diet, supplement B6, B12, folate |
| Feature | Detail |
|---|---|
| Defect | β Homogentisic acid oxidase (in tyrosine catabolism) |
| Triad | Dark urine (homogentisic aciduria) + Ochronosis (black connective tissue) + Arthritis (large joints) |
| Early sign | Diaper staining in infancy |
| Onset | Usually asymptomatic until ~40 years |
| Treatment | β Phenylalanine & tyrosine intake; manage arthritis |
| Vitamin | Role |
|---|---|
| B6 (PLP) | Transamination (all AAs); BCAA catabolism; transsulfuration |
| B12 | Remethylation of homocysteine; propionyl-CoA β succinyl-CoA |
| Folate (THF) | One-carbon transfers; remethylation of homocysteine |
| Biotin | COβ carboxylation (propionyl-CoA β methylmalonyl-CoA) |
| BHβ | Phenylalanine hydroxylase coenzyme |
| Disease | Deficient Enzyme | Key AA | Urine Finding |
|---|---|---|---|
| PKU | Phenylalanine hydroxylase | Phe β | Phenylketones (musty odor) |
| MSUD | BCAA Ξ±-keto acid dehydrogenase | Leu, Ile, Val β | Maple syrup odor |
| Homocystinuria | Cystathionine Ξ²-synthase | Homocysteine β | β Homocysteine |
| Alkaptonuria | Homogentisic acid oxidase | Tyr catabolite β | Darkens on standing |
| Albinism | Tyrosinase | Tyr blocked | - |
| Primary Oxaluria I | Alanine-glyoxylate aminotransferase | Gly β Oxalate | β Oxalate (kidney stones) |